HIV News and Research

RSS
Neutralizing antibodies isolated from COVID-19 patients can quash SARS-CoV-2

Neutralizing antibodies isolated from COVID-19 patients can quash SARS-CoV-2

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

New pathways that could help treat RNA viruses identified

New pathways that could help treat RNA viruses identified

Essential and in danger: Coronavirus sickens, even kills public health workers

Essential and in danger: Coronavirus sickens, even kills public health workers

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Study captures unexpected features of SARS-Cov-2 spike protein

Study captures unexpected features of SARS-Cov-2 spike protein

New tools developed to test the ability of anti-coronavirus antibodies

New tools developed to test the ability of anti-coronavirus antibodies

Benefits of routine childhood immunizations far outweigh the risk of SARS-CoV-2 transmission

Benefits of routine childhood immunizations far outweigh the risk of SARS-CoV-2 transmission

More COVID-19 cases where blood type A is common

More COVID-19 cases where blood type A is common

Study could help develop new drugs for toxoplasma infection

Study could help develop new drugs for toxoplasma infection

Pioneering method reveals the dynamics of HIV Gag lattice structure

Pioneering method reveals the dynamics of HIV Gag lattice structure

Compelling study shows heparin may protect against COVID-19

Compelling study shows heparin may protect against COVID-19

GW researcher receives $3.6 million to study HIV-1 resistance to antibody treatments

GW researcher receives $3.6 million to study HIV-1 resistance to antibody treatments

Weak immune status, and not HIV infection affects cavity prevalence in children

Weak immune status, and not HIV infection affects cavity prevalence in children

Likelihood of SARS-CoV-2 transmission may depend on blood type of spreader and recipient

Likelihood of SARS-CoV-2 transmission may depend on blood type of spreader and recipient

Common FDA-approved drug may be a powerful tool in fighting COVID-19

Common FDA-approved drug may be a powerful tool in fighting COVID-19

International research collaboration to investigate the role of immune system in health

International research collaboration to investigate the role of immune system in health

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

New guidance published for research on HIV, co-infections in pregnancy

New guidance published for research on HIV, co-infections in pregnancy

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus

Concentration of lopinavir and hydroxychloroquine not sufficient to fight novel coronavirus